Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Zajicek

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Health Technology Assessment (Winchester, England)|February 14, 2015
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosisSusan Ball, Jane Vickery, Jeremy Hobart, et al.
BMJ Open|October 10, 2019
Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility studyCamille B Carroll, Douglas Webb, Kara Nicola Stevens, et al.
Health Technology Assessment (Winchester, England)|June 21, 2019
A self-management programme to reduce falls and improve safe mobility in people with secondary progressive MS: the BRiMS feasibility RCTHilary Gunn, Jackie Andrade, Lorna Paul, et al.
JAMA Neurology|July 2, 2016
Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United KingdomPedro María Rodríguez Cruz, Lucy Matthews, Mike Boggild, et al.
Nature Genetics|October 1, 2013
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis, Ashley H Beecham, Nikolaos A Patsopoulos, et al.
Nature|August 12, 2011
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis, , Stephen Sawcer, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Health Technology Assessment (Winchester, England)|February 14, 2015
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosisSusan Ball, Jane Vickery, Jeremy Hobart, et al.
BMJ Open|October 10, 2019
Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility studyCamille B Carroll, Douglas Webb, Kara Nicola Stevens, et al.
Health Technology Assessment (Winchester, England)|June 21, 2019
A self-management programme to reduce falls and improve safe mobility in people with secondary progressive MS: the BRiMS feasibility RCTHilary Gunn, Jackie Andrade, Lorna Paul, et al.
JAMA Neurology|July 2, 2016
Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United KingdomPedro María Rodríguez Cruz, Lucy Matthews, Mike Boggild, et al.
Nature Genetics|October 1, 2013
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis, Ashley H Beecham, Nikolaos A Patsopoulos, et al.
Nature|August 12, 2011
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis, , Stephen Sawcer, et al.
Pageof 3